Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks

Clinical Toxicology

Volumn 35, Issue 2, 1997, Pages 211-212

  Kolecki, Paul ^a  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROHEPTADINE; PHENELZINE; VENLAFAXINE;

ABSTINENCE; ADULT; CASE REPORT; HUMAN; LETTER; MALE; SEROTONIN SYNDROME;

EID: 0030972429     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563659709001196     Document Type: Letter

References (8)

1. Jarrott B, Vajda FJ. The current status of monoamine oxidase and its inhibitors. Med J Aust 1987;146: 634-638.
2. Hodgman M, Martin T, Dean B, Krenzelok E. Severe serotonin syndrome secondary to venlafaxine and maintenance tranylcypromine therapy. J Toxicol Clin Toxicol 1995;33:554.
3. Brubacher JF, Lurin MJ, Hirsch S, Hoffman RS, et al. Serotonin syndrome from venlafaxine-tranylcy-promine interaction. J Toxicol Clin Toxicol 1995;33: 523-524.
4. Klysner R, Larsen JK, Sorensen P, Hyllested M, Pedersen BD. Toxic interaction of venlafaxine and isocarboxazide. Lancet 1995;346:1298-1299.
5. Phillips SD, Ringo P. Phenelzine and venlafaxine interaction. Am J Psychiatry 1995;152:1400-1401.
6. Mills KC. Serotonin syndrome. Am Fam Physician 1995;52:1475-1482.
7. Package insert. Effexor (Venlafaxine hydrochloride). Philadelphia: Wyeth Laboratories, December 1993.
8. Baldessarini RJ. Drugs and the treatment of psychiatric disorders depression and mania. In: Goodman and Gilman 's The Pharmacological Basis of Therapeutics, 9th ed. Harriman JG, Limbird LE, Motinoff PB, Ruddon RW, eds. , Hightstown, NJ: McGraw-Hill, 1996:440.